Institutional investors purchased a net $124.3 thousand shares of OMER during the quarter ended September 2013, and now own 32.49% of the total float, a percentage that is typical for companies in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
OPALEYE MANAGEMENT, INC. Bought 460.0 Thousand shares of Omeros Corp
D. E. SHAW & CO. LP Bought 371.2 Thousand shares of Omeros Corp